Synapse - Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591

Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591 Meeting Abstract

Authors:	Feldman, J. L.; Morris, M. J.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; Martinez, D. F.; Slovin, S. F.; Rathkopf, D. E.; Gonen, M.; Beylergil, V.; Durack, J. C.; Cheal, S. M.; Bander, N. H.; Scher, H. I.; Larson, S. M.; Pandit-Taskar, N.
Abstract Title:	Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
Meeting Title:	2015 Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	7 Suppl.
Meeting Dates:	2015 Feb 26-28
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-03-01
Language:	English
ACCESSION:	WOS:000356886700166
PROVIDER:	wos
DOI:	10.1200/jco.2015.33.7_suppl.164
Notes:	Meeting Abstract: 164 -- Source: Wos